The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Open accessAbstract
Peptide therapeutics have played a notable role in medical practice since the advent of insulin therapy in the 1920s. Over 60 peptide drugs are approved in the United States and other major markets, and peptides continue to enter clinical development at a steady pace. Peptide drug discovery has diversified beyond its traditional focus on endogenous human peptides to include a broader range of structures identified from other natural sources or through medicinal chemistry efforts. We maintain a comprehensive dataset on peptides that have entered human clinical studies that includes over 150 peptides in active development today. Here we provide an overview of the peptide therapeutic landscape, including historical perspectives, molecular characteristics, regulatory benchmarks, and a therapeutic area breakdown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Peptides (2–50 amino acids) and proteins (more than 50 amino acids) have better selectivity for human specific targets. The larger molecular size and diverse quaternary structure enhance their interaction with specific protein pockets, making peptides and protein drugs have better biological activity and lower toxicity than small molecules.294,295”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [294]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Müller, A., Schäberle, T. F., Hughes, D. E., Epstein, S. S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052
Advances in Fmoc solid‐phase peptide synthesis
Behrendt, R., White, P., & Offer, J. (2016) · Journal of Peptide Science · doi:10.1002/psc.2836 · Cited by 767
(1922) · PubMed · Cited by 753
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007218 · Cited by 696
Chang, Y. S., Graves, B. J., Guerlavais, V., Tovar, C., Packman, K. E., To, K.-H., Olson, K. A., Kesavan, K. P., Gangurde, P., Mukherjee, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303002110 · Cited by 681
Strategic Approaches to Optimizing Peptide ADME Properties
Di, L. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9687-3 · Cited by 669
Large-scale manufacture of peptide therapeutics by chemical synthesis
Bray, B. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1133 · Cited by 601
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., Saha, P. K., Del Solar, M., Zhu, B., York, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.063 · Cited by 591
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–900 of 1,001
Liao, J., Zhang, R., Jia, X., Wang, M., Li, C., Wang, J., Tang, R., Huang, J., You, H., & Chen, F. (2024) · Green Chemistry · doi:10.1039/d4gc03864a · Cited by 13
Hong, K., Rong, Y., Jiang, Y., Yuan, J., Wu, F., Gao, L., & Wu, X. (2025) · Food and Bioprocess Technology · doi:10.1007/s11947-025-03755-3 · Cited by 16
Asim, M. N., Asif, T., Mehmood, F., & Dengel, A. R. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109821 · Cited by 14
Recent Advances in the Addition of Amide/Sulfonamide Bonds to Alkynes
Zhao, F., Li, P., Liu, X., Jia, X., Wang, J., & Liu, H. S. (2019) · Molecules · doi:10.3390/molecules24010164 · Cited by 13
Diversity-oriented submonomer synthesis of azapeptides mediated by the Mitsunobu reaction
Dai, C., Ma, J., Li, M., Wu, W., Xia, X., & Zhang, J. (2019) · Organic Chemistry Frontiers · doi:10.1039/c9qo00296k · Cited by 13
Ivachtchenko, A. V., Mitkin, O. D., Kravchenko, D. V., Kovalenko, S. М., Shishkina, S. V., Bunyatyan, N. D., Konovalova, I. S., Геннадиевна, Д. И., Ivanov, V. V., & Langer, T. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02738 · Cited by 13
Antifungal and anti-biofilm activity of designed derivatives from kyotorphin
de Andrade, V. M., Bardajı́, E., Heras, M., Ramu, V. G., Junqueira, J. C., dos Santos, J. D., Castanho, M. A. R. B., & Conceição, K. (2019) · Fungal Biology · doi:10.1016/j.funbio.2019.12.002 · Cited by 13
Peptide Combination Generator: a Tool for Generating Peptide Combinations
Ali, N., Shamoon, A., Yadav, N., & Sharma, T. (2020) · ACS Omega · doi:10.1021/acsomega.9b03848 · Cited by 13
Evolving peptides for oral intake
Brayden, D. J. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0559-0 · Cited by 13
Robinson, R. C., Nielsen, S. D.-H., Dallas, D. C., & Barile, D. (2020) · Food & Function · doi:10.1039/d0fo02439b · Cited by 15
Fluorinated Triazole Foldamers: Folded or Extended Conformational Preferences
Arenas, J. L., Xu, Y., Milcent, T., van Heijenoort, C., Giraud, F., Ha‐Duong, T., Crousse, B., & Ongeri, S. (2021) · ChemPlusChem · doi:10.1002/cplu.202000791 · Cited by 13
Park, H., Ha, E., & Kim, M. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118169 · Cited by 13
Hsiao, Y., Beadle, J. D., Pascoe, C. A., Annadate, R. A., & Vederas, J. C. (2021) · Organic Letters · doi:10.1021/acs.orglett.1c02684 · Cited by 13
Sanchís, I., Spinelli, R., Aschemacher, N. A., & Siano, Á. (2021) · Amino Acids · doi:10.1007/s00726-021-03096-3 · Cited by 13
Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein
Rabbani, G., Ahn, S. N., Kwon, H., Ahmad, K., & Choi, I. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101170 · Cited by 13
Development of Peptide Biopharmaceuticals in Russia
Deigin, V. I., Poluektova, E. A., Герович, Б. А., Kozin, S. A., & Poluektov, Y. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040716 · Cited by 13
General lack of structural characterization of chemically synthesized long peptides
Boutin, J. A., Tartar, A. L., DORSSELAER, A. V., & Vaudry, H. (2019) · Protein Science · doi:10.1002/pro.3601 · Cited by 13
Bahadori, M., Hemmateenejad, B., & Yousefinejad, S. (2019) · Amino Acids · doi:10.1007/s00726-019-02761-y · Cited by 13
Beyond function: Engineering improved peptides for therapeutic applications
Adhikari, S., Leissa, J. A., & Karlsson, A. J. (2019) · AIChE Journal · doi:10.1002/aic.16776 · Cited by 12
Gupta, S., Tiwari, N., Verma, J. K., Waseem, M., Subbarao, N., & Munde, M. M. (2020) · RSC Advances · doi:10.1039/d0ra01773f · Cited by 14
Isolation of Cysteine-Rich Peptides from Citrullus colocynthis
Shahin-Kaleybar, B., Niazi, A., Afsharifar, A., Nematzadeh, G., Yousefi, R., Retzl, B., Hellinger, R., Muratspahić, E., & Gruber, C. W. (2020) · Biomolecules · doi:10.3390/biom10091326 · Cited by 13
D’Addio, S. M., Su, Y., Yin, D., Zhang, J., Kemp, E. A., & Gindy, M. E. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.09.027 · Cited by 13
Peptidomimetics Therapeutics for Retinal Disease
Parsons, D., Hyeon, L. S., Sun, Y. J., Velez, G., Bassuk, A. G., Smith, M. A., & Mahajan, V. B. (2021) · Biomolecules · doi:10.3390/biom11030339 · Cited by 13
Advancing the valorisation of meat co-products in food, pet food, and biomedicine applications
Bou, R., Pinotti, L., Zeugolis, D. I., Watigny, A., & Álvarez, C. (2025) · Waste Management · doi:10.1016/j.wasman.2025.114948 · Cited by 15
Backbone Protecting Groups for Enhanced Peptide and Protein Synthesis
Paravizzini, S. J., Haugaard‐Kedström, L. M., Hutton, C. A., & Karas, J. A. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202509939 · Cited by 12
Accurate structure prediction of cyclic peptides containing unnatural amino acids using HighFold3
Cao, S., Zhu, C., Mao, Q., Guo, J., Zhu, N., & Duan, H. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf488 · Cited by 12
Potential therapeutic applications of AKAP disrupting peptides
Murabito, A., Cnudde, S., Hirsch, E., & Ghigo, A. (2020) · Clinical Science · doi:10.1042/cs20201244 · Cited by 12
Bhushan, B., Granata, D., Kaas, C. S., Kasimova, M. A., Ren, Q., Cramer, C. N., White, M. D., Hansen, A. M. K., Fledelius, C., Invernizzi, G., et al. (2022) · Chemical Science · doi:10.1039/d1sc06844j · Cited by 13
Maçario, I. P. E., Veloso, T., Romão, J., Gonçalves, F. J. M., Pereira, J. L., Duarte, I. F., & Ventura, S. P. M. (2022) · Algal Research · doi:10.1016/j.algal.2022.102792 · Cited by 13
Zhao, S., Song, Z., Liu, T., Wang, X., Li, Y., Xu, Y., Wang, H., Wu, Y., & Luo, X. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.133166 · Cited by 12
Zhang, B., Yu, P., Su, E., Zhang, C.-Y., Xie, S., Yang, X., Zou, Y., Liu, M., & Jiang, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1184588 · Cited by 12
Sun, Y., Yang, L., Cheng, Y., An, G., & Li, G. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.109250 · Cited by 13
EACVP: An ESM-2 LM Framework Combined CNN and CBAM Attention to Predict Anti-coronavirus Peptides
Zhang, S., Jing, Y., & Liang, Y. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673287899240303164403 · Cited by 12
Peptide Drugs: Current Status and it's Applications in the Treatment of Various Diseases
Chandarana, C. V., Juwarwala, I., Shetty, S., & Bose, A. (2024) · Current Drug Research Reviews · doi:10.2174/0125899775295960240406073630 · Cited by 12
Na, T., Sander, V., Davidson, A. J., Lin, R., Hermant, Y. O., Boys, M. T. H., Pletzer, D., Campbell, G., Ferguson, S. A., Cook, G. M., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202407764 · Cited by 12
Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review
Cushman, C. J., Ibrahim, A. F., Smith, A. D., Hernandez, E. J., MacKay, B., & Zumwalt, M. (2024) · The Yale Journal of Biology and Medicine · doi:10.59249/tknm3388 · Cited by 12
Direct and chemoselective transformation of cysteine to dehydroalanine on peptides
Mori, T., Sakata, K., & Shirakawa, S. (2025) · Chemical Communications · doi:10.1039/d5cc00156k · Cited by 12
Hepatic micropeptide modulates mitochondrial RNA processing machinery in hepatocellular carcinoma
Zhu, L., Liu, F., Shi, C., Su, X., Tan, M., Xie, S., Meng, Y., Zou, S., Tan, Y., Xie, S., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.05.027 · Cited by 13
Okuda-Shinagawa, N. M., Moskalenko, Y. E., Junqueira, H. C., Baptista, M. S., Marques, C. M., & de Miranda, M. T. M. (2017) · ACS Omega · doi:10.1021/acsomega.7b01127 · Cited by 12
Real-Time Imaging and Quantification of Peptide Uptake in Vitro and in Vivo
Karataş, H., Maric, T., D’Alessandro, P. L., Yevtodiyenko, A., Vorherr, T. E., Hollingworth, G. J., & Goun, E. A. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00439 · Cited by 12
Gőz, V. G., Nagy, A., Farkas, V., Keszei, E., & Perczel, A. (2019) · RSC Advances · doi:10.1039/c9ra06124j · Cited by 12
Pandey, A. P., Singh, D., Dhas, N. L., Tewari, A. K., Pathak, K., Chatap, V. K., Rathore, K. S., & Mutalik, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817776-1.00008-0 · Cited by 12
Structure-based design of small bicyclic peptide inhibitors of Cripto-1 activity
Iaccarino, E., Calvanese, L., Untiveros, G., Falcigno, L., D’Auria, G., Latino, D., Sivaccumar, J. P., Strizzi, L., Ruvo, M., & Sandomenico, A. (2020) · Biochemical Journal · doi:10.1042/bcj20190953 · Cited by 12
Outlaw, V. K., Kreitler, D. F., Stelitano, D., Porotto, M., Moscona, A., & Gellman, S. H. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00385 · Cited by 12
Yang, Y., Mao, H. Z., Chen, L., & Li, L. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108776 · Cited by 12
La‐Venia, A., Dzijak, R., Rampmaier, R., & Vrábel, M. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202102042 · Cited by 12
Xia, Y., To, J., Chan, N., Hu, S., Liew, H. T., Balamkundu, S., Zhang, X., Lescar, J., Bhattacharjya, S., Tam, J. P., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202108125 · Cited by 12
Xiao, R., Luo, S., Zhang, T., Lv, Y.-K., Wang, T., Zhang, J., Yuan, S., Ruiz, M., Dupuis, J., Zhu, L., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16712 · Cited by 12
Deciphering the Limitations and Antibacterial Mechanism of Cruzioseptins
Rivera, F. V., Bermúdez-Puga, S., Proaño‐Bolaños, C., & Almeida, J. R. (2022) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-022-10383-4 · Cited by 12
Solid‐Phase Total Synthesis of Yaku'amide B Enabled by Traceless Staudinger Ligation
Itoh, H., Miura, K., Kamiya, K., Yamashita, T., & Inoue, M. (2020) · Angewandte Chemie · doi:10.1002/ange.201916517 · Cited by 12
Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics
Garsi, J.-B., Komjáti, B., Cullia, G., Fejes, I., Sipos, M., Sipos, Z., Fördős, E., Markacz, P., Balázs, B., Lancelot, N., et al. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00094 · Cited by 13
Tuning of Peptide Cytotoxicity with Cell Penetrating Motif Activatable by Matrix Metalloproteinase-2
Lee, J., Oh, E., Lee, H., Lee, E., Kim, H. G., Park, H. J., & Kim, C. (2022) · ACS Omega · doi:10.1021/acsomega.2c02127 · Cited by 12
Sharma, K., Aaghaz, S., Maurya, I. K., Sharma, K. K., Singh, S., Rudramurthy, S. M., Kumar, V., Tikoo, K., & Jain, R. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106252 · Cited by 12
Tang, Y., Arbaugh, B. M., Park, H., Scher, H. B., Bai, L., Mao, L., & Jeoh, T. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104063 · Cited by 12
Flitcroft, C. E., Jolliffe, K. A., & McErlean, C. S. P. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202301083 · Cited by 12
Cui, Z. Y., Wang, S., He, Y., Chen, Z., & Zhang, Q. (2023) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2023.3290014 · Cited by 12
Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in Plasmodium falciparum
Bennett, J. M., Ward, K. E., Muir, R. K., Kabeche, S. C., Yoo, E., Yeo, T., Lam, G., Zhang, H., Almaliti, J., Berger, G., et al. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00310 · Cited by 12
Hayashi, Y., Hirose, T., Iwatsuki, M., Ōmura, S., & Sunazuka, T. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b02966 · Cited by 12
Naturally occurring antitubercular cyclic peptides
Zhang, S., Kavianinia, I., & Brimble, M. A. (2019) · Tetrahedron Letters · doi:10.1016/j.tetlet.2019.151339 · Cited by 12
Mechanisms Inspired Targeting Peptides
Yuan, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3266-5_21 · Cited by 12
Nasako, H., Takashina, Y., Eguchi, H., Ito, A., Ishikawa, Y., Matsunaga, T., Endo, S., & Ikari, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165909 · Cited by 12
Hiratsuka, T., Ogura, I., Okamura, A., Fushimi, H., Yamaguchi, K., & Nishimura, I. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00986 · Cited by 12
Conventional Nanosized Drug Delivery Systems for Cancer Applications
Vergallo, C., Hafeez, M. N., Iannotta, D., Santos, H. A., d’Avanzo, N., Dini, L., Cilurzo, F., Fresta, M., Marzio, L. D., & Christian, C. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-58174-9_1 · Cited by 12
Murugan, N. A., Raja, K. M. P., & Saraswathi, N. T. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-0267-2_10 · Cited by 12
Synthesis and conformation of backbone N-aminated peptides
Rathman, B. M., Rowe, J. L., & Valle, J. R. D. (2021) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2021.04.013 · Cited by 12
Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy
Niu, Y.-X., Xu, Z., Yu, L., Lu, Y., Wang, Y., Wu, C., Hou, Y.-B., Li, J., Huang, S., Song, X., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108783 · Cited by 12
Looking for SARS-CoV-2 Therapeutics Through Computational Approaches
Vincenzi, M., Mercurio, F. A., & Leone, M. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666221004104430 · Cited by 13
The Importance of Amide Protons in Peptide Drug Development
Harrington, A., & Tal‐Gan, Y. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0238 · Cited by 12
Nagaraj, H., Lehot, V., Nasim, N., Çiçek, Y. A., Goswami, R., Jeon, T., & Rotello, V. M. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00129c · Cited by 12
Liu, Y., Meng, J., Yue, M., Jiao, C., Zhao, Z., Sun, Y., Chang, Y., Wu, H., Yan, X., Song, K., et al. (2025) · Energy & Environmental Science · doi:10.1039/d5ee05434f · Cited by 11
Chen, T., Sun, T., Bian, Y., Pei, Y., Feng, F., Chi, H., Li, Y., Tang, X., Sang, S., Du, C., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01456 · Cited by 11
Subcutaneous catabolism of peptide therapeutics: bioanalytical approaches and ADME considerations
Esposito, S., Orsatti, L., & Pucci, V. (2022) · Xenobiotica · doi:10.1080/00498254.2022.2119180 · Cited by 11
Anti-Melanogenesis Effects of a Cyclic Peptide Derived from Flaxseed via Inhibition of CREB Pathway
Yoon, J. H., Jang, W. Y., Park, S. H., Kim, H. G., Shim, Y. Y., Reaney, M. J. T., & Cho, J. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010536 · Cited by 13
Wu, A., & Yamamoto, H. (2023) · Chemical Science · doi:10.1039/d3sc01239e · Cited by 11
Pritam, M., Dutta, S., Medicherla, K. M., Kumar, R., & Singh, S. P. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2239932 · Cited by 11
Balde, A., Kim, S., & Nazeer, R. A. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141963 · Cited by 11
Permeation Enhancer‐based Ionogel Shows Remarkable Potential for Oral Insulin Delivery
Raptis, K., Heade, J., da Cunha, C. F. B., van de Weert, M., Saaby, L., Rønholt, S., & Nielsen, H. M. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500946 · Cited by 11
De novo design of D-peptide ligands: Application to influenza virus hemagglutinin
Juraszek, J., Kadam, R. U., Branduardi, D., van Ameijde, J., Garg, D., Dailly, N., Jongeneelen, M. A. C., Vermond, J., Brakenhoff, J. P. J., Brandenburg, B., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2426554122 · Cited by 11
Takenaga, K., Ochiya, T., & Endo, H. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5173 · Cited by 11
Zheng, X., Zhu, L., Li, T., Xu, W., Liu, D., Sheng, J., Cao, H., Shi, Y., & Wang, F. (2021) · ACS Catalysis · doi:10.1021/acscatal.1c00955 · Cited by 11
Recombinant Active Peptides and their Therapeutic Functions
Ajingi, Y. S., Rukying, N., Aroonsri, A., & Jongruja, N. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201022666210702123934 · Cited by 12
Yadav, M. K., & Eswari, S. (2022) · Avicenna Journal of Medical Biotechnology · doi:10.18502/ajmb.v14i1.8172 · Cited by 11
Des3PI: a fragment-based approach to design cyclic peptides targeting protein–protein interactions
Delaunay, M., & Ha‐Duong, T. (2022) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-022-00468-z · Cited by 11
Wu, A., Ramakrishna, I., Hattori, T., & Yamamoto, H. (2022) · Organic & Biomolecular Chemistry · doi:10.1039/d2ob01795d · Cited by 11
3D self-assembled nanocarriers for drug delivery
Mirzahosseini, H. K., Sheikhi, M., Najmeddin, F., Shirangi, M., & Mojtahedzadeh, M. (2023) · Drug Metabolism Reviews · doi:10.1080/03602532.2023.2172182 · Cited by 11
Molecular Peptide Grafting as a Tool to Create Novel Protein Therapeutics
Komar, A. A. (2023) · Molecules · doi:10.3390/molecules28052383 · Cited by 11
Elnahriry, K. A., Wai, D. C. C., Ashwood, L. M., Naseem, M. U., Szanto, T. G., Guo, S., Panyi, G., Prentis, P. J., & Norton, R. S. (2023) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2023.140952 · Cited by 11
Peptide-based non-viral gene delivery: A comprehensive review of the advances and challenges
Xiang, K., Li, Y., Cong, H., Yu, B., & Shen, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131194 · Cited by 11
Schwaar, T., Lettow, M., Remmler, D., Börner, H. G., & Weller, M. G. (2019) · Microarrays · doi:10.3390/ht8020011 · Cited by 11
A New Cyclase Family Catalyzing Head-to-Tail Macrolactamization of Non-ribosomal Peptides
Matsuda, K., Kuranaga, T., & Wakimoto, T. (2019) · Journal of Synthetic Organic Chemistry Japan · doi:10.5059/yukigoseikyokaishi.77.1106 · Cited by 11
Acosta, G., Murray, L., Royo, M., de la Torre, B. G., & Alberício, F. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00298 · Cited by 11
In Silico Modelling in the Development of Novel Radiolabelled Peptide Probes
Kleynhans, J., Kruger, H. G., Cloete, T. T., Zeevaart, J. R., & Ebenhan, T. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200504082256 · Cited by 11
Sharma, G., Deuis, J. R., Jia, X., Mueller, A., Vetter, I., & Mobli, M. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114148 · Cited by 11
Zhang, Y.-B., Ouyang, M., Wang, H.-L., Zhang, B., Guang, W.-H., Liu, R.-W., Li, X.-C., Shih, T.-C., Li, Z., Cao, J., et al. (2020) · MedComm · doi:10.1002/mco2.48 · Cited by 9
Peptides: Molecular and Biotechnological Aspects
Cabral, H. (2021) · Biomolecules · doi:10.3390/biom11010052 · Cited by 12
K., P. V., Rath, S. P., & Abraham, P. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251913 · Cited by 11
Stability and antiviral activity of SP40 peptide in human serum
Zarif, F., Anasir, M. I., Koh, J. X., Chew, M.-F., & Poh, C. L. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198456 · Cited by 11
Large scale peptide screening against main protease of SARS CoV ‐2
Uddin, M. J., Akhter, H., Chowdhury, U., Mawah, J., Karim, S. T., Jomel, M., Islam, M. S., Islam, M. R., Onin, L. A. B., Ali, M., et al. (2022) · Journal of Computational Chemistry · doi:10.1002/jcc.27050 · Cited by 11
Targeted EpCAM-binding for the development of potent and effective anticancer proteins
Liu, Z., Zhang, C., Cui, B., Wang, Y., Lim, K., Li, K., Thiery, J. P., Chen, J., & Ho, C. L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114443 · Cited by 11
Metadata
- Authors
- Lau, J. L., & Dunn, M. K.
- Affiliations
- Ferring Research Institute (United States) (US)
- Corresponding author
- Dunn, Michael K.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 26
- Issue
- 10
- Pages
- 2700-2707
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W2724823461
- Cited by
- 1,879
- References
- 44
- Citations by year
- 2026: 146 · 2025: 179 · 2024: 205 · 2023: 236 · 2022: 299 · 2021: 275 · 2020: 278 · 2019: 194 · 2018: 59
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Bioorganic & Medicinal Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- peptide therapeutics, peptide drug discovery, clinical development, insulin, therapeutic areas
- MeSH terms
- Animals, Drug Evaluation, Humans, Peptides, Drug Approval, Drug Discovery, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review